BRCA2 and familial pancreatic carcinoma: In one recent cohort study of over 300 patients with pancreatic cancer, pathologic germline mutations in BRCA2 were identified in 3.3%, BRCA1 mutations in 1.2%, and PALB2 in 0% [17].